Indication
Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation
2 clinical trials
4 products
Clinical trial
A Phase II Trial to Evaluate Combination Therapy With Pemetrexed and Avelumab in Previously Treated Patients With MTAP-Deficient Advanced Urothelial CancerStatus: Active (not recruiting), Estimated PCD: 2025-01-31
Product
AvelumabProduct
PemetrexedClinical trial
A Phase I/Ib Open Label, Single-Arm Study of Cabozantinib in Combination With Enfortumab Vedotin (EV) in the Treatment of Locally Advanced or Metastatic Urothelial CancerStatus: Recruiting, Estimated PCD: 2025-01-21
Product
CabozantinibProduct
Enfortumab Vedotin